Clinical and epidemiological descriptions from trichinellosis outbreaks in Bulgaria.


Journal

Experimental parasitology
ISSN: 1090-2449
Titre abrégé: Exp Parasitol
Pays: United States
ID NLM: 0370713

Informations de publication

Date de publication:
May 2020
Historique:
received: 08 10 2019
revised: 03 03 2020
accepted: 10 03 2020
pubmed: 18 3 2020
medline: 28 4 2020
entrez: 18 3 2020
Statut: ppublish

Résumé

Bulgaria is one of European countries where trichinellosis continues to be regularly diagnosed and registered. The clinical and epidemiological features of 72 cases of trichinellosis associated with five outbreaks caused by Trichinella spiralis and Trichinella britovi between 2009 and 2011, are described. At hospital admission, patients were often initially treated with antibiotics, without any improvement. A range of signs and symptoms were recorded, including: myalgia, elevated temperature, arthralgia, difficulty with movement, facial oedema, conjunctival hyperaemia, ocular haemorrhages, diarrhoea, skin rash, headache, and fatigue. Due to the variable clinical course of the disease, the diagnostic process for trichinellosis is often complex and difficult. This means the diagnosis may be established late for an appropriate treatment, potentially leading to a severe course of the disease with complications. Laboratory abnormalities were expressed by marked eosinophilia (97.2%), leucocytosis (70.8%), elevated serum creatine phosphokinase levels (82%), and antibody-positive results by ELISA and indirect hemagglutination. Patients were treated with albendazole (Zentel) 10 mg/kg for 7-10 days. In two outbreaks, the aetiological agent was T. spiralis, in one outbreak T. britovi, and an unknown Trichinella species in the fourth outbreak. The sources of infection were domestic pigs, probably fed with scraps and offal of wild game. In one outbreak, T. spiralis was also detected in brown rats trapped close to where the pig had been raised in the backyard. These epidemiological factors are relevant in considering implementation of targeted control programmes.

Identifiants

pubmed: 32179068
pii: S0014-4894(19)30447-3
doi: 10.1016/j.exppara.2020.107874
pii:
doi:

Substances chimiques

Antiprotozoal Agents 0
Creatine Kinase EC 2.7.3.2
Albendazole F4216019LN

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107874

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Kamenna Vutova (K)

Department of Infectious Diseases, Parasitology and Tropical Medicine, Medical University - Sofia, Specialized Hospital of Infectious and Parasitic Diseases "Prof. I. Kirov", 1606, Acad. I. Geshov Blvd 17, Sofia, Bulgaria. Electronic address: k_vutova@abv.bg.

Valeri Velev (V)

Department of Infectious Diseases, Parasitology and Tropical Medicine, Medical University - Sofia, Specialized Hospital of Infectious and Parasitic Diseases "Prof. I. Kirov", 1606, Acad. I. Geshov Blvd 17, Sofia, Bulgaria.

Rositza Chipeva (R)

Department of Infectious Diseases, Parasitology and Tropical Medicine, Medical University - Sofia, Specialized Hospital of Infectious and Parasitic Diseases "Prof. I. Kirov", 1606, Acad. I. Geshov Blvd 17, Sofia, Bulgaria.

Nina Yancheva (N)

Department of Infectious Diseases, Parasitology and Tropical Medicine, Medical University - Sofia, Specialized Hospital of Infectious and Parasitic Diseases "Prof. I. Kirov", 1606, Acad. I. Geshov Blvd 17, Sofia, Bulgaria.

Svetlozara Petkova (S)

Bulgarian Academy of Sciences, Institute of Experimental Morphology, Pathology and Anthropology with Museum, Acad. G. Bonchev Str., Bl. 25, 1113, Sofia, Bulgaria.

Toma Tomov (T)

Department of Infectious Diseases, Parasitology and Tropical Medicine, Medical University - Sofia, Specialized Hospital of Infectious and Parasitic Diseases "Prof. I. Kirov", 1606, Acad. I. Geshov Blvd 17, Sofia, Bulgaria.

Edoardo Pozio (E)

Department of Infectious Diseases, Istituto Superiore di Sanita, Viale Regina Elena 299, 00161, Rome, Italy.

Lucy J Robertson (LJ)

Parasitology Lab, Department of Paraclinical Sciences, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Adamstuen Campus, PO Box 369 Sentrum, 0102, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH